Navigation follows, skip to content? New England Baptist Hospital Logo Utility navigation follows, skip to content? Primary navigation follows, skip to content?

Press Room

Christopher Collins, co-founder and Managing Director of Boston-based First Atlantic Capital, LLC, has been elected to the Board of Trustees of New England Baptist Hospital

Effective July 19, 2017, Christopher Collins, co-founder and Managing Director of Boston-based First Atlantic Capital, LLC, has been elected to the Board of Trustees of New England Baptist Hospital. NEBH is the premier Boston hospital for orthopedic surgery and the treatment of musculoskeletal disorders.

Erven “Sam” Samsel, Chairman of the NEBH board, enthusiastically welcomed Mr. Collins “as an accomplished executive with extraordinary business acumen and is an exceptional community leader. The addition of Christopher Collins to our Board of Trustees will further assist us in positioning the Baptist brand of orthopedic care into new markets as we grow.”

About New England Baptist Hospital

New England Baptist Hospital (NEBH) is the premier regional provider for orthopedic surgery and the treatment of musculoskeletal diseases and disorders. NEBH has been nationally recognized for high patient satisfaction and leadership in quality and clinical outcomes. The Hospital is committed to improving the health and well-being of those living throughout its community by providing opportunities for people of all ages to be active, stay social and keep moving. NEBH is a teaching affiliate of Tufts University School of Medicine and conducts teaching programs in collaboration with Harvard Medical School. NEBH is celebrating its 30th year as the official hospital of the Boston Celtics. 

 

Return to the Press Room

Footer navigation follows, return to top?

Our Cookie Policy

Your privacy is important to us. We use cookies and other tracking technologies to ensure the performance and security of our website and to monitor website use for business and website optimization purposes. This may include disclosures about your use of the website to third parties. By using our website, you agree to its use of these technologies. To learn more, please read our Terms of Use.